Literature DB >> 6394553

[Clinical aspects and etiology of acrodermatitis chronica atrophicans].

K Weber, G Schierz, B Wilske, V Preac-Mursic.   

Abstract

We followed up nine patients with acrodermatitis chronica atrophicans (ACA) for an average of 2 years (6-44 months). Extradermal symptoms were observed in five patients, three of whom developed systemic signs such as fatigue or general sensitivity to cold; three suffered from cardiac symptoms; and two had joint and/or nervous system involvement. In one patient, erythema migrans and oligoarthralgia preceded the ACA. In most patients, the laboratory tests showed changes often seen in inflammatory diseases; we found an elevation of IgA, IgG and/or IgM in five patients. Using an indirect immunofluorescence test with Ixodes dammini spirochetes as antigen, the patients had more or less elevated IgG antibody titers and insignificant IgM antibody titers; similar results were obtained in some patients when an Ixodes ricinus spirochete isolated in the area of Munich was used as antigen. We believe that ACA is a chronic spirochetosis with manifestations present in the skin, joints, nervous system, and presumably in the heart.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394553

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

1.  [Multiple erythema].

Authors:  B Brunner; U Neubert; M J Flaig; C A Sander
Journal:  Hautarzt       Date:  2003-03-25       Impact factor: 0.751

2.  Spirochetes isolated from two patients with morphea.

Authors:  K Weber; V Preac-Mursic; C D Reimers
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

4.  Persistent atrioventricular block in Lyme borreliosis.

Authors:  W Mayer; F X Kleber; B Wilske; V Preac-Mursic; W Maciejewski; H Sigl; E Holzer; W Doering
Journal:  Klin Wochenschr       Date:  1990-04-17

5.  Characterization of Finnish Borrelia burgdorferi sensu lato isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and with monoclonal antibodies.

Authors:  J Tuomi; L K Rantamäki; R Tanskanen; J Junttila
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Passive immunization of hamsters against experimental infection with the Lyme disease spirochete.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.

Authors:  G Zumstein; R Fuchs; A Hofmann; V Preac-Mursic; E Soutschek; B Wilske
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

8.  An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Authors:  B Wilske; V Preac-Mursic; U B Göbel; B Graf; S Jauris; E Soutschek; E Schwab; G Zumstein
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.